packageObinutuzumab

obinutuzumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Obinutuzumab is a monoclonal antibody used to treat B-cell blood cancers such as chronic lymphocytic leukemia and various lymphomas. It is approved and authorised in the European Union for chronic lymphocytic leukemia, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q389496 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:obinutuzumab
ATC codes:L01FA03
DrugBank:DB08935
Wikidata:Q389496
molar mass:146100 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown